Literature DB >> 2702078

The immune system in minimal change nephrotic syndrome.

H W Schnaper1.   

Abstract

Numerous examples of abnormal immune responsiveness have been described in minimal change nephrotic syndrome (MCNS). The of MCNS with allergy and with certain genetic markers of immune responsiveness, as well as the excellent response of proteinuria to immunomodulatory agents, has suggested a causal relationship between the immunological and renal abnormalities. However, the nature of this relationship is uncertain. Before it can be clarified, the basic mechanism(s) involved in disturbed immunity in patients with MCNS must be better characterized. Studies of humoral and cellular immune function support the hypothesis that immune regulation is abnormal. However, conclusive evidence of participation by a defined immunoregulatory system in the events leading to immune dysfunction has not been obtained. Thus, considerable work remains to be done in determining the nature and cause of abnormal immunity in MCNS prior to investigating its potential role in the pathogenesis of proteinuria.

Entities:  

Mesh:

Year:  1989        PMID: 2702078     DOI: 10.1007/BF00859637

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  114 in total

1.  Nephrosis treated by malaria; results in 65 cases.

Authors:  D GAIRDNER; P G SHUTE
Journal:  Lancet       Date:  1955-11-05       Impact factor: 79.321

2.  The role of allergy in nephrosis.

Authors:  A G DESANCTIS; V J FONTANA; W C SPAIN
Journal:  N Y State J Med       Date:  1956-12-15

3.  Inhibition of proteoglycan synthesis eliminates the proteoglycan form of Ia-associated invariant chain and depresses antigen presentation.

Authors:  L E Sivak; M R Harris; C Kindle; S E Cullen
Journal:  J Immunol       Date:  1987-03-01       Impact factor: 5.422

4.  Lymphocyte subpopulations in minimal change nephrotic syndrome.

Authors:  H O Kerpen; J G Bhat; R Kantor; B Gauthier; K R Rai; R G Schacht; D S Baldwin
Journal:  Clin Immunol Immunopathol       Date:  1979-09

5.  Inhibition of lymphocyte blastogenesis by plasma of patients with minimal-change nephrotic syndrome.

Authors:  A V Moorthy; S W Zimmerman; P M Burkholder
Journal:  Lancet       Date:  1976-05-29       Impact factor: 79.321

6.  Serum hemolytic factor D values in children with steroid-responsive idiopathic nephrotic syndrome.

Authors:  M Ballow; T L Kennedy; K M Gaudio; N J Siegel; R H McLean
Journal:  J Pediatr       Date:  1982-02       Impact factor: 4.406

7.  Immune complexes in children with different forms of glomerulonephritis.

Authors:  K Madaliński; T Wyszyńska; B Mikulska; H Lukasiewicz; W Madaliński; A Borowski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1983       Impact factor: 4.291

8.  The inhibition of complement-dependent lymphocyte rosette formation by the sera of children with steroid-sensitive hephrotic syndrome and other renal diseases.

Authors:  M D Smith; T M Barratt; A R Hayward; J F Soothill
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

9.  Nodular sclerosing Hodgkin's disease presenting as nephrotic syndrome.

Authors:  W F Cale; I H Ullrich; J J Jenkins
Journal:  South Med J       Date:  1982-05       Impact factor: 0.954

10.  Synthesis and release of platelet-activating factor by stimulated human mononuclear phagocytes.

Authors:  M R Elstad; S M Prescott; T M McIntyre; G A Zimmerman
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

View more
  28 in total

1.  MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome.

Authors:  Eva Cuzzoni; Raffaella Franca; Sara De Iudicibus; Annalisa Marcuzzi; Marianna Lucafò; Marco Pelin; Diego Favretto; Elena Monti; William Morello; Luciana Ghio; Claudio La Scola; Francesca Mencarelli; Andrea Pasini; Giovanni Montini; Giuliana Decorti; Gabriele Stocco
Journal:  Eur J Clin Pharmacol       Date:  2019-08-28       Impact factor: 2.953

Review 2.  Bacterial persistence and expression of disease.

Authors:  G J Domingue; H B Woody
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

Review 3.  A conceptual framework for the molecular pathogenesis of progressive kidney disease.

Authors:  H William Schnaper; Susan C Hubchak; Constance E Runyan; James A Browne; Gal Finer; Xiaoying Liu; Tomoko Hayashida
Journal:  Pediatr Nephrol       Date:  2010-03-30       Impact factor: 3.714

4.  Serum and urine soluble interleukin-2 receptor in idiopathic nephrotic syndrome.

Authors:  G H Bock; J R Ongkingco; L T Patterson; J Ruley; L R Schroepfer; D L Nelson
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

5.  Current status of vaccines and immune globulins for children with renal disease.

Authors:  R W Steele
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

6.  Immunization practices in childhood nephrotic syndrome: a survey of North American pediatric nephrologists.

Authors:  H W Schnaper
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

Review 7.  Consensus statement on management and audit potential for steroid responsive nephrotic syndrome. Report of a Workshop by the British Association for Paediatric Nephrology and Research Unit, Royal College of Physicians.

Authors: 
Journal:  Arch Dis Child       Date:  1994-02       Impact factor: 3.791

8.  Human leucocyte antigens in idiopathic nephrotic syndrome in children.

Authors:  H Ruder; K Schärer; G Opelz; V Lenhard; R Waldherr; D E Müller-Wiefel; A M Wingen; J Dippell
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

9.  T-cell subsets, interleukin-2 receptor expression and production of interleukin-2 in minimal change nephrotic syndrome.

Authors:  R Topaloğlu; U Saatçi; M Arikan; H Canpinar; A Bakkaloğlu; E Kansu
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

10.  Reduced response to hepatitis B virus vaccination in boys with steroid-sensitive nephrotic syndrome.

Authors:  A La Manna; C Polito; A C Foglia; A Di Toro; M R Cafaro; R Del Gado
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.